Cost-Effectiveness Analysis of Adjuvant Treatment for Resected Pancreatic Cancer in China Based on the ESPAC-4 Trial

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s172704
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Comparative Effectiveness of Adjuvant Treatments for Resected Gastric Cancer: A Network Meta-Analysis

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis

Frontiers in Oncology
Cancer ResearchOncology
2019English

PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Cost-Effectiveness of FOLFIRINOX for First-Line Treatment of Metastatic Pancreatic Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Cost-Effectiveness of FOLFIRINOX for First-Line Treatment of Metastatic Pancreatic Cancer

Current Oncology
Oncology
2013English

Role of Adjuvant Therapy in Resected Stage IA Subcentimeter (T1a/T1b) Pancreatic Cancer

Cancer
Cancer ResearchOncology
2018English

Prm248 - Referenced-Based Imputation for the Cost-Effectiveness Analysis of Longitudinal Randomised Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Histamine Type 2 Receptor Antagonists as Adjuvant Treatment for Resected Colorectal Cancer

Clinical Journal of Oncology Nursing
Oncology
2013English

Cost-Utility and Cost-Effectiveness of Internet-Based Treatment for Adults With Depressive Symptoms: Randomized Trial

Journal of Medical Internet Research
Health Informatics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy